rfhg_16203.1

Basic information about the TSS

---

TSS ID: rfhg_16203.1 Species: human Chr: chr1		Start: 175000310 End: 175000317 Strand: +
Source datasets	PRJNA615891
Protocol	SLIC_CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000405362.1:-97 GeneID: 27101 HGNC/MGI_ID: HGNC:30423 UniProt_ID: Q9HB71 Nearer transcript ids and distances: ENST00000406752.1:-129 AY423723:-130 AF275803:-188 BC078151:-219 BC067823:-234 AF057356:-243 AL035305:-246 BC022352:-251 AF314752:-253 AK294042:-268 BC005865:-318 AK313278:-345 ENST00000473925.1:-355 BC005975:-355 ENST00000367679.7:-363 NM_014412.3:-363 ENST00000483307.1:-365 view more...

Gene_name: calcyclin binding protein Gene_symbol: CACYBP Gene_synonyms: S100A6BP SIP Gene_source: HGNC:30423

TATA-Box annotation

---

Distance to TSS:	366
Nearest PromoterID:	NM_014412
Entrez ID:	27101
Nearest Unigene:	Hs.508524
Nearest Refseq:	NM_014412
Nearest Ensembl:	ENSG00000116161
Gene Name:	calcyclin binding protein
Gene Alias:	GIG5|PNAS-107|S100A6BP|SIP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CACYBP p2@CACYBP p3@CACYBP p4@CACYBP p5@CACYBP p7@CACYBP p9@CACYBP
Sample		p1@CACYBP	p2@CACYBP	p3@CACYBP	p4@CACYBP	p5@CACYBP	p7@CACYBP	p9@CACYBP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	84.93	52.60	0.78	1.36	1.95	0.39	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	77.49	52.60	1.42	2.23	2.23	0.00	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	76.58	55.75	1.93	2.12	2.70	0.19	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	60.92	38.88	2.49	1.46	1.25	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	74.01	48.14	1.35	2.02	1.57	0.22	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	62.41	40.70	2.52	2.33	0.97	0.19	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	88.68	61.88	1.74	2.18	2.61	0.87	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	75.09	56.92	2.42	2.18	4.12	0.24	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	62.83	56.21	1.07	1.71	1.28	0.00	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.36	45.79	1.16	2.90	1.74	0.00	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.06	36.79	1.21	3.23	2.83	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	32.12	39.44	0.41	1.63	3.25	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.76	24.82	0.48	0.64	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.02	21.35	0.30	0.15	0.15	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.32	21.52	0.44	0.44	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.17	18.11	0.25	1.01	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.90	15.51	1.75	1.09	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	17.72	0.00	0.42	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	19.73	0.00	0.53	0.53	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.65	19.26	1.05	0.45	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.87	23.12	1.20	0.27	0.13	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	31.59	20.89	1.04	1.73	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.21	22.62	0.39	0.78	0.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.42	18.20	0.49	0.73	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	23.22	17.29	0.26	1.29	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.05	20.89	0.32	0.32	0.95	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.77	19.78	0.55	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.95	21.69	0.24	1.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.65	19.06	0.48	0.48	0.48	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.86	20.81	0.72	1.09	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.70	17.17	0.21	1.05	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.99	18.95	0.78	0.39	0.20	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	26.59	20.47	0.21	1.27	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.83	24.08	0.49	0.99	0.82	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	27.11	22.06	0.56	1.12	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.08	21.46	0.77	1.72	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	28.00	17.99	0.41	0.61	0.41	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	22.97	20.15	0.20	1.41	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.36	19.99	1.08	0.54	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.33	20.65	0.00	0.00	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.29	18.82	0.24	1.18	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.72	20.06	0.73	0.73	0.59	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	24.04	18.98	0.42	0.84	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	26.22	16.96	0.17	1.22	0.52	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.11	25.90	0.40	1.61	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.26	20.01	0.93	0.70	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.27	21.11	0.24	0.72	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.65	21.76	1.49	1.19	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	23.94	19.39	0.24	0.48	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.22	14.96	0.20	0.40	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.27	17.42	0.41	1.43	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.46	21.35	0.44	0.67	0.67	0.22	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	125.93	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.48	15.61	1.42	1.42	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.93	17.89	0.00	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	39.43	47.82	5.87	4.19	2.52	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	26.64	25.26	0.92	1.84	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.21	12.32	0.32	1.30	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.34	16.38	0.32	1.28	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.00	21.06	0.94	1.26	1.26	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	13.40	0.00	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	8.97	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	29.46	23.88	1.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	15.97	1.02	1.02	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.45	13.00	0.32	0.65	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	12.07	0.00	0.35	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	64.66	16.16	16.16	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	150.05	0.00	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	14.63	0.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.36	12.89	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	15.48	0.94	0.94	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.22	21.53	0.00	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.21	20.11	0.31	0.62	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.37	20.48	0.31	0.31	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	26.93	16.95	0.48	1.11	0.95	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	39.79	17.01	0.64	0.16	0.48	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	28.12	17.56	1.02	1.15	1.15	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	26.16	15.70	1.49	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	27.46	12.73	0.67	0.33	0.00	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	30.62	16.59	0.00	1.28	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	13.19	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	45.16	28.90	3.61	0.45	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	37.19	19.98	0.70	0.52	0.00	0.52	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	38.53	28.94	0.78	0.39	0.39	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	23.42	17.76	0.51	0.51	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	53.52	37.36	0.84	1.12	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	54.67	40.56	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	139.31	60.97	1.13	1.61	0.80	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	47.12	26.47	0.32	0.00	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	35.19	11.73	1.60	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	84.58	32.83	0.56	1.11	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	91.91	43.25	0.83	1.25	1.25	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	38.68	24.36	1.00	1.51	1.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	60.21	27.16	0.00	1.64	0.65	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	74.60	35.01	0.61	0.91	0.30	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	46.41	39.12	0.88	0.22	0.66	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	11.83	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	3.59	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.31	23.39	0.18	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	10.04	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.20	14.38	0.00	0.00	0.21	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	31.70	16.13	1.60	0.57	0.34	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	24.98	8.82	0.98	0.24	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	18.87	1.80	0.00	0.00	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	28.22	16.93	1.74	0.00	0.87	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	17.12	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	27.50	15.84	0.30	0.90	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	13.91	3.79	5.06	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	28.38	12.54	0.66	0.00	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.29	17.54	1.30	0.32	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	35.44	22.33	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.29	10.10	1.78	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	27.12	16.20	1.51	0.38	0.75	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	27.58	14.51	0.73	0.00	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	20.06	1.25	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	39.87	19.93	1.98	0.82	0.49	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	43.67	17.74	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.63	15.38	0.75	0.15	0.30	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	29.47	18.75	1.07	0.00	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	33.82	14.36	0.76	0.38	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	30.74	16.30	0.80	0.53	0.27	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	29.26	14.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.85	14.10	1.49	0.66	0.17	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	26.42	15.61	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	10.62	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.19	13.72	1.03	0.00	0.17	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	8.39	0.00	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	26.21	13.11	1.94	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.57	13.28	1.52	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	6.06	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.79	13.11	1.71	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.58	13.90	1.28	0.00	0.21	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.71	17.29	1.29	0.00	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	11.26	0.00	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	27.33	15.43	0.96	0.32	0.32	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.84	18.55	1.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.76	15.79	0.58	0.00	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	27.70	15.66	0.30	0.00	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	36.83	11.88	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	17.29	2.03	0.00	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.13	20.38	1.53	0.25	0.25	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	31.77	13.34	1.27	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	29.34	15.54	0.86	0.86	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	35.77	16.09	0.64	0.21	0.42	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.81	11.31	1.16	0.87	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	14.17	0.94	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.28	16.78	0.85	0.17	0.17	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	13.90	2.32	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	10.56	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	30.23	14.37	1.29	0.64	0.21	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.28	9.63	0.00	1.20	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	27.70	17.50	1.46	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	29.42	15.17	2.07	0.00	0.00	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	0.00	0.00	0.00	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.24	15.25	1.27	0.51	0.76	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	31.79	14.45	0.83	0.00	0.21	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.81	9.49	1.53	0.00	0.00	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	28.68	15.30	0.00	0.00	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.16	14.41	1.11	0.44	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	7.63	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	14.95	0.00	0.00	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.04	14.83	0.79	1.32	0.26	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.44	11.99	0.00	0.00	0.00	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	27.63	33.90	1.23	0.00	0.12	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	14.38	16.94	0.51	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.03	8.18	0.00	0.00	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	44.27	63.79	0.70	1.05	0.35	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	57.59	59.69	0.65	1.46	1.29	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	47.88	68.61	0.60	1.19	0.30	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	106.08	118.01	10.67	3.44	1.72	2.64	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	147.58	127.16	9.27	4.89	2.51	2.63	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	130.52	129.05	8.53	5.58	1.93	3.64	0.68
Basophils, donor1	12241-129G9	11.51	23.01	1.57	1.57	0.00	0.00	0.26
Basophils, donor2	12242-129H1	36.44	30.31	5.41	2.89	0.36	2.16	0.00
Basophils, donor3	12243-129H2	14.85	27.64	2.50	1.62	0.59	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	6.90	7.76	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	3.20	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	35.87	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	55.23	21.34	1.26	0.63	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	25.79	21.21	0.62	0.42	0.00	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	14.74	15.66	0.00	0.00	0.69	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	24.83	19.07	0.36	0.54	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	159.74	111.09	17.52	8.14	4.84	1.85	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	182.13	111.79	14.21	2.79	1.40	1.86	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	63.32	77.39	7.35	2.88	0.32	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	82.74	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.96	18.03	2.82	1.69	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	10.39	14.66	3.16	1.67	0.37	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	8.34	16.03	2.63	0.88	0.00	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	71.33	30.57	6.79	1.98	0.85	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	63.31	41.32	7.20	1.90	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.36	44.71	8.88	0.99	0.00	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	9.97	14.17	3.90	2.02	0.72	0.72	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	8.15	9.96	3.02	1.81	0.60	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	12.79	13.74	3.32	0.95	0.71	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.69	5.02	2.34	1.17	0.50	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.11	6.90	3.59	4.14	0.55	0.55	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.11	5.45	2.23	1.98	1.49	0.50	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.87	5.29	1.96	1.96	0.59	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.04	5.52	2.31	1.07	1.07	0.71	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.72	7.83	5.88	3.26	2.83	0.22	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.32	8.66	1.87	1.40	0.70	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	21.12	8.98	4.75	2.11	2.64	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	9.98	4.44	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.72	5.21	3.87	1.93	1.19	0.00	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	11.37	5.39	5.39	2.00	0.80	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	27.69	10.20	7.70	2.91	2.91	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	6.63	1.60	2.52	0.69	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.46	4.98	4.75	1.36	0.68	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	5.24	2.62	2.18	0.87	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	6.46	1.08	0.54	0.81	0.00	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.64	7.68	2.79	3.14	0.35	0.17	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.73	5.89	4.21	1.68	1.26	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.65	2.76	2.76	2.02	1.10	0.18	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	4.58	1.41	1.06	0.35	0.00	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.95	3.07	1.75	1.75	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	5.58	3.31	2.62	1.39	1.05	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	8.55	6.32	2.23	0.74	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.73	12.93	3.02	3.88	1.94	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	5.32	1.23	1.23	0.82	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.58	5.56	2.55	2.09	0.70	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.57	6.96	3.94	2.78	0.93	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	41.63	43.59	9.15	1.31	0.65	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	27.49	31.18	6.01	0.92	0.23	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	44.41	42.24	11.70	1.52	0.22	1.95	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	21.96	34.10	4.67	2.18	0.62	0.31	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	17.46	30.39	5.24	1.92	0.87	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	32.78	51.73	10.93	1.11	0.45	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	38.53	41.59	5.61	1.53	0.26	0.00	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	32.06	37.33	8.56	0.66	0.66	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	51.16	48.22	11.37	1.26	1.26	2.32	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	79.26	6.10	4.06	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	58.31	72.54	10.17	0.68	2.71	0.68	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	64.21	13.46	0.00	1.04	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	44.24	55.44	7.46	3.20	0.00	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	61.11	74.51	11.79	2.68	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	56.86	70.90	3.51	4.21	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.20	69.81	11.77	3.92	3.14	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	50.09	83.05	14.50	3.95	3.95	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	17.26	12.33	1.64	0.82	0.82	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	9.43	13.78	3.63	7.25	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	9.09	9.09	3.03	4.54	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	139.00	86.47	1.21	25.86	14.14	1.21	3.64
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	99.47	61.92	3.20	15.58	10.79	1.60	3.99
CD34+ Progenitors, donor1	11545-120B6	13.05	30.12	0.00	4.02	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	20.79	33.15	10.67	1.69	0.00	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	93.56	105.59	9.02	3.76	1.13	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	89.52	107.10	6.54	4.06	0.68	1.80	0.68
CD4+ T Cells, donor1	11225-116C1	73.91	66.77	6.07	2.14	0.71	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	63.07	45.93	6.74	2.45	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	50.02	51.24	2.44	1.83	1.22	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	106.43	59.73	9.44	0.77	0.51	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	109.60	58.40	9.21	1.57	0.67	1.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	92.27	49.73	10.92	1.44	0.57	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	55.94	68.74	2.84	4.27	0.47	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	44.25	89.90	3.51	3.51	3.51	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	46.15	6.59	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	104.20	62.86	12.14	1.30	1.30	1.30	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	154.21	65.24	9.32	1.86	0.85	1.69	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	122.36	55.94	10.32	2.10	0.64	1.93	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	58.28	66.35	4.03	2.24	1.34	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	68.83	80.71	3.84	3.49	2.10	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	65.56	77.44	7.04	2.20	1.76	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	84.75	56.08	11.81	1.26	0.42	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	84.15	44.05	6.23	2.08	0.21	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.52	39.43	6.01	2.00	2.34	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	49.49	59.28	4.89	4.89	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	43.41	61.63	6.97	2.68	1.61	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	62.76	57.38	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	112.55	69.54	7.79	3.52	3.34	1.11	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	110.04	67.15	8.01	2.38	0.65	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	94.78	56.74	6.94	2.10	0.63	1.68	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	54.10	83.93	6.07	2.02	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	71.92	89.68	2.17	3.47	0.43	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	82.80	90.21	3.05	2.61	1.31	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.84	134.11	2.97	2.47	0.99	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	70.16	110.78	0.92	2.77	0.92	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	117.25	2.79	1.40	1.40	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.88	123.79	5.54	0.55	0.55	1.66	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	75.09	129.81	7.12	0.74	2.21	1.47	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	56.98	104.72	7.70	0.00	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	59.81	116.39	2.86	2.86	1.07	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	69.25	120.49	4.15	5.54	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	50.75	45.18	4.91	2.29	0.33	1.96	0.33
CD8+ T Cells, donor2	11307-117C2	33.79	36.79	1.50	0.75	0.00	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	38.88	42.42	2.52	0.76	0.25	1.77	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	59.64	30.51	9.86	0.23	0.92	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	42.66	19.89	11.26	0.96	1.44	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.05	22.16	8.48	1.37	0.27	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	54.94	24.62	14.11	0.30	1.50	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	43.44	25.20	7.20	0.24	1.44	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.34	25.92	7.28	1.14	1.14	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	80.18	30.20	14.34	1.09	0.43	1.52	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	65.27	34.74	13.95	0.79	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	77.16	29.78	12.43	1.17	0.00	1.17	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	87.85	40.75	13.89	0.30	1.81	1.81	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	67.98	32.83	12.20	0.87	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	81.00	39.97	13.06	1.60	0.80	0.53	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	45.96	14.88	12.69	0.44	0.88	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	67.86	19.13	16.85	0.46	0.00	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.18	20.14	8.20	0.00	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	42.50	24.13	9.36	0.36	0.72	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	44.88	24.46	6.04	0.58	0.58	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.29	17.68	5.89	0.94	0.47	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.89	34.86	11.73	0.63	0.32	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	83.66	33.52	11.07	1.23	0.00	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	77.90	38.15	9.62	0.64	1.28	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	75.35	31.36	9.56	0.76	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	75.67	38.62	8.67	0.00	1.58	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	58.24	22.69	16.64	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.83	22.48	13.65	0.80	0.00	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	60.85	27.28	11.19	1.40	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	68.12	19.03	8.01	0.00	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	30.14	19.27	1.48	1.48	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	48.20	35.78	1.05	2.10	0.53	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	68.99	28.08	2.77	3.47	0.00	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	18.48	18.48	0.00	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	28.67	16.04	1.25	0.46	0.23	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	42.97	47.45	1.79	0.00	0.90	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	16.98	15.37	0.81	0.81	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	51.30	54.85	1.84	1.38	0.23	0.46	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	38.26	33.99	1.07	1.28	0.43	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	43.72	36.28	0.97	0.97	0.53	0.35	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.96	23.29	1.38	6.97	4.68	0.46	1.47
Corneal Epithelial Cells, donor1	11526-119I5	8.78	9.88	0.00	0.22	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	12.51	14.79	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	19.94	15.59	0.26	0.26	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	54.32	12.55	57.95	1.32	1.16	9.25	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	58.98	13.56	57.09	1.58	0.63	6.62	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	13.80	58.66	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	37.15	8.32	38.12	0.86	0.32	2.27	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.11	39.29	3.42	2.73	1.02	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	51.58	6.53	1.96	0.00	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.01	30.00	7.26	0.48	0.97	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	54.20	36.86	0.50	1.33	0.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	35.79	17.60	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	48.64	31.11	0.57	1.41	0.00	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	31.45	18.09	0.00	0.39	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	25.31	20.65	0.87	0.58	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	53.41	23.76	0.71	1.18	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	39.44	27.70	0.70	0.18	0.00	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.67	23.72	1.77	0.89	0.44	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.55	26.17	1.83	0.30	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	38.06	22.27	1.97	0.28	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	33.58	19.02	1.19	0.30	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	32.28	17.70	1.04	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.90	9.36	0.43	0.43	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	121.24	63.22	4.40	0.80	0.80	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.92	13.63	0.52	1.05	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	119.77	75.79	2.98	4.47	0.99	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	71.26	62.14	0.43	1.09	0.43	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	105.88	80.97	1.47	1.34	1.10	0.24	0.61
Endothelial Cells - Vein, donor1	11267-116G7	29.58	20.48	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	32.83	25.15	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	57.31	31.40	0.79	1.57	0.31	0.16	0.16
Eosinophils, donor1	12244-129H3	60.99	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	37.96	1.65	4.95	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	10.70	3.57	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	8.80	0.00	0.00	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	50.08	31.61	0.41	1.64	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.96	7.45	0.77	0.99	0.44	0.55	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	46.69	24.92	1.30	1.63	1.30	0.22	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	75.44	46.21	1.46	1.82	0.85	0.73	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.48	16.24	0.55	0.41	0.27	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.49	17.93	0.95	0.74	0.42	0.53	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.99	16.86	0.26	0.79	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	89.36	45.84	1.00	1.33	1.00	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	40.37	19.05	1.36	0.00	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	14.40	12.13	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	19.08	12.78	0.63	0.79	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	49.10	35.16	1.82	0.61	0.61	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	53.43	32.11	0.89	0.51	0.25	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	91.41	45.18	1.82	1.06	1.21	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.12	17.69	0.40	0.13	0.13	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	9.06	0.43	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	62.99	38.08	0.00	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	28.14	32.29	0.23	0.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	32.90	20.52	1.53	0.51	0.51	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	47.43	18.31	0.47	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	68.87	41.98	0.00	0.94	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	50.53	23.94	0.97	0.48	0.60	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	93.15	82.07	0.90	0.79	0.90	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	120.90	75.54	1.74	0.87	0.87	0.87	0.70
Fibroblast - Dermal, donor6	11458-119A9	146.83	100.86	2.44	2.11	1.62	0.81	0.49
Fibroblast - Gingival, donor1	11237-116D4	64.76	28.32	0.42	0.42	0.62	1.04	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.14	24.10	1.05	1.05	1.31	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	104.90	66.55	0.53	1.19	0.79	1.05	0.53
Fibroblast - Gingival, donor3	11394-118C8	43.61	19.72	0.87	0.48	0.48	0.39	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	10.39	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	30.48	17.97	0.35	0.70	0.00	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	89.95	53.16	1.56	2.96	1.87	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	82.76	46.11	1.08	1.22	0.95	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	11.29	6.70	0.35	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	72.39	39.92	1.17	1.90	0.29	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	80.86	38.72	2.05	1.09	0.82	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	110.68	60.88	0.66	3.95	0.88	0.44	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.55	19.66	1.47	0.15	0.44	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	21.75	4.08	2.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	52.23	47.75	4.48	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	60.36	44.53	0.42	1.27	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	29.99	21.66	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	8.39	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	4.48	0.00	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	56.02	35.32	0.41	0.81	0.41	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	3.99	19.97	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	122.01	86.90	1.36	4.66	0.78	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	110.42	85.55	1.06	2.28	0.46	0.46	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	108.32	59.67	0.31	1.84	0.92	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.14	39.31	1.53	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.54	22.41	0.81	1.08	0.00	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.54	17.40	0.58	0.23	0.23	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	106.55	61.46	1.88	3.09	0.99	0.66	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	42.06	23.37	0.00	0.20	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.06	24.06	0.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	46.26	27.28	1.19	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	44.85	35.72	0.99	0.79	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	35.88	23.27	1.42	0.71	1.07	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.61	31.93	2.17	0.79	0.20	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	46.63	25.27	0.90	0.90	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	85.61	38.00	3.67	0.43	0.54	0.86	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	32.90	19.23	0.51	0.25	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	45.94	25.27	0.82	0.49	0.33	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	65.37	46.72	1.00	1.20	0.40	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	79.06	42.80	2.31	1.41	1.11	1.11	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	45.03	30.22	0.00	0.60	0.91	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.72	24.85	1.33	0.83	0.50	0.25	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	67.18	34.02	3.08	0.85	0.85	1.54	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.27	16.75	0.33	0.33	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	79.78	55.60	1.28	1.07	1.28	1.07	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	80.97	47.40	1.35	0.67	1.18	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	40.93	27.76	0.78	1.25	1.25	0.78	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1285.27	487.52	44.32	22.16	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	27.89	0.87	0.87	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	53.05	31.20	0.35	0.87	0.17	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	65.58	36.69	1.04	0.52	0.78	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	62.60	36.79	0.51	0.51	0.26	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	111.77	122.49	0.77	3.06	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	124.42	129.53	1.28	6.38	0.64	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	222.22	236.20	2.28	9.41	3.14	0.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	111.13	101.20	0.55	2.21	0.55	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	61.88	63.25	0.46	1.83	0.91	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	148.00	160.29	0.99	5.75	1.59	0.59	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	99.65	90.93	1.06	1.59	0.79	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	83.49	60.01	1.30	0.65	0.98	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	187.95	217.57	0.88	7.96	0.88	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	84.23	101.19	1.41	2.97	0.85	0.57	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	84.48	78.20	1.72	1.23	1.11	0.99	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	90.26	90.80	1.34	3.22	0.00	1.07	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	65.17	86.97	1.36	2.11	0.74	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	68.66	94.68	0.97	2.08	1.38	0.83	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	65.67	73.39	1.22	3.25	1.02	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	55.90	52.02	0.68	2.51	0.00	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	71.75	60.91	1.00	1.49	0.37	0.75	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	58.36	61.20	1.09	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	62.35	56.44	0.89	2.07	0.00	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	67.56	67.88	0.64	0.64	0.48	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	70.38	60.10	1.12	0.45	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	56.66	60.29	0.60	2.02	0.60	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	83.97	77.53	2.04	2.21	0.68	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	100.55	76.44	2.22	2.13	0.98	0.89	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.57	67.74	2.50	1.35	0.94	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.17	66.43	2.39	2.05	0.68	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	76.35	57.65	1.99	1.22	1.00	0.66	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	86.36	65.97	2.25	1.33	1.16	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	91.06	71.46	1.63	1.43	0.41	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	49.93	51.78	2.89	0.62	0.21	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	67.79	52.57	1.27	0.81	0.23	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	76.38	52.70	1.67	1.00	0.17	0.67	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.65	40.78	0.66	1.76	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	72.44	54.73	2.46	1.97	0.61	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	61.27	52.36	1.78	0.81	0.65	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	47.15	44.58	2.57	0.96	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	53.06	51.17	1.23	0.95	0.28	0.38	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	52.67	49.98	3.16	1.42	0.79	0.95	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	44.40	45.00	1.22	1.52	0.61	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	67.64	51.33	0.73	1.05	0.52	0.63	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	48.52	35.79	1.32	0.66	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	52.18	44.89	1.68	0.28	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.39	39.72	0.83	0.28	0.83	0.65	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	73.54	50.54	2.41	1.07	0.80	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	72.52	51.41	1.22	0.92	1.22	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	70.21	46.50	1.30	0.65	0.65	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	64.24	37.41	1.36	0.81	0.54	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	42.03	38.16	0.74	0.92	0.55	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.28	34.21	1.10	1.54	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	23.80	1.98	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.19	37.73	0.13	1.06	0.26	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	41.36	33.90	0.00	0.81	0.40	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	27.96	28.21	0.76	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	143.92	190.90	2.39	2.99	1.19	1.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	97.84	113.86	1.54	1.85	0.62	0.62	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	114.57	141.98	0.82	2.66	2.05	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	122.04	164.60	0.63	3.13	1.56	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	122.35	174.34	1.41	5.09	2.54	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	109.31	149.89	0.00	2.77	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	123.74	158.39	2.47	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	138.86	153.95	3.87	4.64	0.77	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	155.63	113.92	1.60	3.21	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	93.90	90.42	0.00	3.48	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	120.75	123.36	2.28	3.58	1.63	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	120.25	132.19	2.06	3.29	1.24	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	83.31	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	121.65	98.16	2.24	3.08	0.84	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	108.51	104.26	1.96	4.58	1.63	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	71.30	75.50	0.84	0.84	2.52	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	124.37	89.70	0.64	3.50	0.95	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	113.11	105.30	2.38	4.42	1.36	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	96.05	79.35	4.18	4.18	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	99.65	90.49	1.72	1.72	3.44	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	69.26	74.88	1.18	1.48	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	105.04	72.85	0.00	5.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	102.72	93.20	3.73	2.90	0.83	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	90.67	95.96	1.61	2.07	0.69	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	105.37	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	69.96	71.12	1.54	3.46	0.77	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	59.00	78.23	1.30	0.65	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	62.20	65.55	1.34	1.34	2.01	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	63.18	73.59	1.93	2.31	1.54	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	90.04	73.26	3.08	3.08	1.03	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	54.67	0.00	0.00	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	84.46	4.25	4.25	1.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	70.01	81.47	4.22	1.21	1.81	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.60	75.28	0.51	3.05	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	79.77	84.15	3.99	3.19	1.20	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.67	68.58	4.93	3.45	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	81.45	81.45	0.00	1.18	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.93	83.43	1.17	1.75	1.17	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	62.32	63.20	0.88	1.76	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	58.49	1.70	3.39	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.35	54.32	1.19	1.79	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	61.14	58.23	2.91	2.43	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	5.71	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.05	9.98	0.83	0.00	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	33.73	20.24	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.96	8.88	0.63	0.32	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	6.68	0.42	0.00	0.42	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	215.14	96.90	5.22	4.64	1.97	1.97	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	227.71	92.17	3.88	4.56	2.03	1.69	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	246.16	95.55	5.01	3.41	2.96	1.14	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	214.46	92.04	4.48	4.70	2.84	2.19	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	207.39	96.93	4.51	3.87	2.15	1.72	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	215.28	97.31	5.17	4.52	2.58	1.94	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	216.94	92.41	4.86	3.74	1.25	1.62	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	206.72	89.55	2.23	3.60	2.06	1.54	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	206.64	94.83	6.09	3.52	1.60	1.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.18	21.27	1.12	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	12.55	0.00	0.43	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	42.30	26.44	5.29	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.46	17.99	0.00	0.00	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	7.99	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	76.58	45.11	2.27	2.97	0.87	0.17	0.70
Hepatocyte, donor1	11523-119I2	18.16	13.32	0.00	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	45.25	21.55	1.08	0.00	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	23.93	20.86	0.00	1.23	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	128.58	68.53	3.26	9.14	0.65	2.61	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	74.46	45.62	0.87	1.57	0.17	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	53.51	33.89	1.37	0.96	0.69	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	31.84	0.00	3.18	3.18	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	42.92	23.53	0.00	4.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	45.05	20.02	0.00	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	47.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	12.81	0.00	5.13	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	27.42	4.57	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	68.22	34.11	0.00	9.75	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	28.34	1.67	6.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	29.04	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	23.82	0.00	11.91	2.65	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	29.93	0.00	7.76	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	15.71	0.00	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	72.43	35.27	1.89	6.30	1.26	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	26.29	3.09	3.09	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	43.90	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.02	30.36	1.29	5.81	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	40.25	14.49	0.00	1.61	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	11.95	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	64.38	31.78	1.63	5.70	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.75	18.05	0.00	0.84	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	73.94	35.36	0.80	6.43	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	66.48	31.39	0.92	2.77	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	86.85	45.32	0.94	2.83	1.42	0.47	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	73.47	22.67	0.91	3.63	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	67.80	39.82	1.08	3.23	2.15	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	52.09	38.11	1.27	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	42.72	22.96	0.00	1.28	2.55	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	65.62	12.76	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	15.80	0.00	0.00	31.61
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	46.41	35.70	0.71	3.57	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	16.59	0.00	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	79.02	39.20	0.93	2.78	1.85	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	28.10	1.76	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	31.43	0.00	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	47.29	32.68	0.70	1.39	1.39	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	24.34	2.21	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	48.63	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	30.52	24.41	0.00	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	20.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	24.39	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	53.34	27.74	2.13	2.13	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	16.63	1.39	2.77	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	11.40	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	50.62	31.29	0.92	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	15.13	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	12.42	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	19.03	0.00	0.00	0.00	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	26.76	12.08	0.41	0.33	0.24	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	11.13	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	94.47	50.74	0.95	1.51	0.28	0.66	0.19
Keratinocyte - oral, donor1	11251-116E9	55.96	39.05	1.36	1.14	0.34	0.11	0.11
Keratocytes, donor1	11527-119I6	19.60	23.72	0.34	0.00	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	14.06	18.75	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	34.97	13.24	0.40	0.99	0.40	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	127.48	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	40.99	29.13	2.16	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	33.56	48.09	0.23	0.69	0.12	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	30.07	23.51	0.81	0.50	0.50	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	38.66	26.68	1.07	0.71	0.36	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	21.49	21.77	1.12	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.21	19.36	1.57	1.26	0.79	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.73	24.73	0.00	1.61	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	19.23	15.76	0.00	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.59	17.03	0.32	0.54	0.54	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.01	19.70	0.00	1.23	2.46	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.69	12.89	0.25	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	15.76	1.27	0.84	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	28.08	18.99	2.77	0.79	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.40	18.61	0.19	0.58	0.00	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.26	9.44	0.00	0.37	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	32.40	21.60	0.70	1.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.84	15.74	0.24	0.24	0.95	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.93	16.21	0.41	0.96	1.37	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.72	20.94	0.62	0.92	0.31	0.00	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	11.53	0.00	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.12	15.74	0.37	0.37	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.99	24.35	0.66	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.47	14.94	0.88	0.00	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.44	9.96	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.83	23.76	0.48	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.85	19.93	0.54	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.19	18.17	0.45	0.76	0.61	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	15.55	1.04	0.52	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	24.71	20.73	0.21	1.05	0.21	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.60	15.79	0.45	0.60	0.90	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	22.70	0.69	2.75	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	21.45	19.19	0.56	0.75	0.19	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.93	15.37	0.21	0.42	0.32	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	23.74	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.52	17.53	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.62	15.11	0.12	0.37	0.37	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.25	25.17	1.11	0.37	0.74	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.27	17.79	0.49	0.74	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.71	12.37	0.41	0.27	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	26.05	24.77	0.32	0.00	0.00	0.32	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.91	22.52	0.61	0.91	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.69	21.13	0.84	0.98	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	32.71	20.27	1.42	0.36	0.71	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	15.03	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.74	9.80	0.16	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.01	31.16	0.36	1.07	0.72	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.60	19.60	0.33	0.33	0.65	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.54	12.71	0.71	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.62	30.81	0.99	0.87	0.74	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	12.81	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	18.20	0.60	0.00	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	15.86	0.00	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.86	31.45	0.00	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	43.05	22.27	2.23	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.93	21.58	1.27	2.12	1.27	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	44.31	23.21	0.70	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	33.62	19.61	0.93	0.93	0.93	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	33.49	21.64	3.09	1.03	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	27.36	17.84	1.19	2.38	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.37	29.41	0.90	1.36	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	51.77	31.99	2.33	1.45	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	58.52	34.66	1.35	2.25	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	44.85	26.15	0.95	0.54	0.54	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	21.57	1.54	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	54.69	34.58	2.12	1.06	1.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	57.97	29.98	0.67	3.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	39.73	22.41	1.53	2.04	0.51	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	57.36	38.69	1.07	1.33	1.07	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	63.67	42.89	2.83	0.94	0.19	0.76	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.02	23.93	0.61	2.45	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	30.99	0.00	2.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.52	37.28	2.08	1.87	1.46	1.04	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	64.46	33.91	1.68	1.68	0.84	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	52.55	32.97	1.03	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	72.87	38.61	2.03	0.87	0.58	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	61.58	31.99	1.20	1.20	0.90	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	53.67	36.51	2.77	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	49.84	25.45	1.06	2.47	1.06	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	51.63	30.61	1.11	1.11	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	29.93	2.30	2.30	0.00	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	43.75	28.01	1.92	0.77	0.00	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	42.46	20.95	0.57	0.57	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.95	32.00	0.00	0.00	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.05	24.40	0.90	0.00	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	48.12	25.85	1.44	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	68.72	32.12	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	47.56	21.18	1.49	0.74	1.49	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	54.70	31.01	0.43	0.43	1.29	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.09	21.41	2.57	1.71	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	46.31	32.98	1.00	1.33	0.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	35.60	22.93	1.21	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	23.46	2.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	45.03	25.44	1.37	1.03	0.34	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.74	22.01	0.00	0.54	1.61	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	39.73	21.55	0.67	2.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.78	25.93	1.85	2.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	55.82	41.87	2.33	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	40.19	22.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.82	25.61	1.20	0.80	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	36.34	18.90	0.73	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	46.76	23.00	0.77	0.00	0.77	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.85	21.21	1.48	1.48	0.99	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	35.76	17.88	0.94	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	25.14	0.50	0.50	0.50	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.50	20.73	1.35	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	12.05	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	23.60	0.89	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.28	19.94	0.39	0.78	0.78	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.31	17.15	0.00	0.66	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.32	21.79	1.04	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.01	25.38	0.44	0.88	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	34.11	24.60	1.12	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	36.21	26.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	44.36	28.16	1.93	1.54	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.55	24.81	0.51	1.01	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	40.37	34.12	1.44	1.44	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.77	34.19	1.99	1.59	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.06	20.05	0.61	0.61	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	32.51	20.06	0.69	0.69	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	36.10	25.08	1.52	0.76	1.14	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	41.83	25.30	2.07	2.07	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	23.58	17.53	1.21	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	42.46	28.52	0.95	1.27	0.00	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	43.71	19.72	0.00	0.00	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.91	27.01	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	31.37	23.14	0.00	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	18.39	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	39.16	22.70	2.27	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.52	24.55	1.25	1.66	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	41.50	20.36	0.00	1.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.91	18.37	1.25	0.84	0.00	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	37.17	19.98	0.93	0.46	0.46	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	25.42	18.73	1.34	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	36.36	28.87	1.07	0.00	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	42.83	24.25	0.40	0.81	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	43.13	15.60	0.00	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.01	28.45	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.87	22.79	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	18.41	0.77	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	61.28	25.72	0.55	1.09	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	41.87	19.15	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	42.11	30.67	0.52	0.78	1.04	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	42.44	19.23	0.00	0.66	0.66	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	12.47	4.16	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	68.15	20.28	10.26	1.14	0.23	1.60	0.00
Macrophage - monocyte derived, donor2	11313-117C8	34.68	21.29	20.55	1.84	1.10	3.85	0.18
Macrophage - monocyte derived, donor3	11389-118C3	48.11	19.79	11.40	0.92	0.52	3.28	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.38	21.24	0.00	1.06	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	41.51	23.61	0.79	0.63	0.79	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	86.73	45.03	1.25	0.97	1.11	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	62.97	45.04	1.99	1.30	1.00	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	78.18	47.20	1.74	2.32	0.58	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	36.17	23.20	0.50	0.25	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	26.44	28.47	10.85	5.42	0.68	2.03	0.00
Mast cell, donor1	11563-120D6	38.07	37.42	11.14	1.08	0.22	1.62	0.11
Mast cell, donor2	11565-120D8	78.45	56.46	7.13	0.89	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	58.31	64.16	3.83	0.45	0.45	0.45	0.23
Mast cell, donor4	11567-120E1	97.15	51.77	4.25	1.24	0.89	0.89	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	61.99	48.90	19.41	1.89	0.78	3.66	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	21.60	20.43	2.33	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	60.80	51.17	9.87	1.95	1.38	1.84	0.00
Mast cell, expanded, donor8	11941-126A6	48.20	31.97	13.56	1.00	0.50	1.34	0.17
Melanocyte - dark, donor1	11502-119F8	68.26	52.63	2.49	2.09	0.90	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	31.15	17.65	2.08	0.69	0.00	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	143.29	62.30	5.43	1.30	0.65	1.45	0.14
Melanocyte - light, donor1	11274-116H5	18.57	9.64	0.71	0.47	0.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	17.06	8.19	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	7.81	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	132.66	52.69	2.60	1.25	0.94	0.31	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	92.25	41.15	2.96	2.15	1.08	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	56.79	23.57	1.87	1.87	0.54	0.80	0.00
Meningeal Cells, donor1	11493-119E8	72.70	62.15	1.36	0.50	1.12	0.25	0.00
Meningeal Cells, donor2	11573-120E7	55.02	31.25	0.44	0.44	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	136.43	84.76	2.85	2.69	1.55	0.82	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	75.85	66.73	1.14	1.71	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.18	19.62	0.91	0.81	0.30	0.40	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	10.51	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	14.39	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	68.17	48.80	4.31	0.72	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.12	18.64	0.85	0.21	0.64	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.24	17.09	0.50	0.50	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.49	23.51	0.00	0.88	0.66	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	31.42	25.57	0.73	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	23.12	20.05	0.00	0.20	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	28.53	20.08	1.11	0.14	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.32	5.20	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	33.16	20.26	1.71	1.18	0.53	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	3.26	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.21	13.45	0.00	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	105.98	78.33	2.84	4.25	1.77	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.84	27.21	0.31	0.94	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	61.68	47.17	1.45	2.18	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	36.33	23.87	0.27	0.27	1.33	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	27.03	18.52	1.50	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	30.28	17.49	0.43	0.29	0.22	0.36	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	45.91	8.10	0.00	1.35	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	51.23	19.70	17.98	1.97	0.99	1.97	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.40	16.49	12.96	0.59	0.29	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	24.20	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.04	13.02	10.54	0.93	0.62	0.93	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	25.93	10.58	10.58	0.83	0.83	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	20.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.79	19.77	15.52	1.50	0.75	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.60	12.10	5.59	0.00	1.86	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	36.38	13.82	11.58	1.22	0.41	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	23.36	14.65	9.50	1.19	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	51.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.09	7.96	9.73	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	33.81	11.78	11.40	2.28	0.76	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	19.74	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.68	12.52	12.73	1.49	0.85	0.85	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	14.73	9.21	0.92	0.00	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.72	12.22	4.77	0.89	0.60	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	8.38	6.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.62	11.79	11.04	0.50	1.00	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.83	9.51	6.42	1.19	0.24	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	18.80	14.93	3.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.17	11.74	10.82	2.07	0.69	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.30	10.31	7.15	0.84	0.21	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.31	7.34	6.73	0.41	0.41	0.82	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.46	12.44	11.16	1.93	0.64	0.43	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.45	8.45	4.67	0.22	0.22	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	30.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.08	7.23	4.82	1.31	0.66	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	8.62	5.07	0.51	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	9.94	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.29	9.78	8.15	1.09	0.27	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	7.94	3.82	0.29	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	9.81	2.18	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.97	8.17	6.25	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.21	6.80	4.80	0.00	0.80	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	2.74	1.37	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	7.01	4.00	0.50	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.51	6.13	3.50	1.31	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	8.83	1.10	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	8.33	1.92	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	8.43	2.73	1.24	0.99	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	6.26	3.48	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.68	7.52	3.76	1.03	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.44	6.13	1.75	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.24	10.30	1.07	0.71	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.75	10.94	1.68	0.84	0.56	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.56	8.73	3.33	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	5.24	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.97	7.54	2.41	0.30	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.44	10.43	5.01	0.00	0.42	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	9.24	2.77	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.59	11.38	4.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	25.98	9.26	3.18	0.28	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.10	10.37	3.37	0.52	0.52	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.88	9.44	3.43	0.43	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	6.99	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	11.21	2.40	0.53	0.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.33	12.27	6.88	0.60	0.90	1.80	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.74	10.74	1.98	0.28	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.02	10.83	4.46	0.64	0.32	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.64	8.18	6.19	0.44	0.00	1.33	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.96	7.58	2.28	0.00	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	34.09	13.64	7.67	1.14	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	37.12	8.36	7.13	0.74	0.25	1.72	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	15.64	8.47	0.65	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	33.23	17.05	5.59	2.06	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.14	11.24	10.96	1.15	0.00	2.31	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.73	17.31	4.53	1.65	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.05	14.00	5.66	0.00	0.60	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	11.30	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	24.95	7.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	57.83	23.00	10.19	1.31	0.99	3.61	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	21.04	13.68	3.16	0.00	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	58.12	21.15	14.23	1.38	0.40	2.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	35.39	29.80	13.04	1.86	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	59.33	21.78	10.51	1.88	0.38	3.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.36	16.51	11.72	0.53	0.53	1.86	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	78.72	22.96	9.05	2.15	0.90	0.79	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	34.63	20.63	2.95	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	45.80	17.22	6.23	1.10	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	12.44	9.33	0.00	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	85.51	21.38	19.24	2.14	0.53	3.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	11.59	7.73	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	42.42	14.14	11.11	1.01	0.00	3.03	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	41.74	13.07	9.28	1.69	0.42	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	57.20	5.45	16.34	0.00	4.09	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	29.88	10.81	10.17	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	42.92	12.96	18.63	1.62	1.62	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	6.04	9.06	0.00	0.00	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	211.28	17.13	34.26	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	13.05	65.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	4.75	33.27	0.00	4.75	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	60.32	30.38	1.72	0.86	0.65	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	41.81	36.06	1.57	1.57	1.05	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.70	20.02	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.03	20.45	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.06	38.98	2.28	0.38	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	161.18	92.56	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	24.48	11.56	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	176.41	104.75	5.51	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.93	11.30	1.26	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	35.10	16.27	0.46	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.48	12.70	0.54	0.00	0.00	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.95	23.34	0.84	0.63	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	322.91	133.62	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	5.96	0.99	0.50	0.50	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.22	8.93	0.54	0.54	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.45	7.48	0.23	0.45	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.33	9.80	0.33	0.16	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	36.09	22.42	1.82	0.18	0.36	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.03	5.83	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	5.40	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	40.04	16.08	2.95	0.66	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.80	7.48	0.33	0.49	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	44.27	23.64	1.41	0.35	0.53	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	6.33	0.00	0.00	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	8.27	0.46	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	10.28	0.00	0.32	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.94	14.49	1.03	1.03	0.69	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	176.99	70.80	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.67	25.62	0.22	0.00	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	11.43	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.36	8.54	0.24	0.47	0.47	0.95	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.32	9.44	0.00	0.43	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	252.78	63.19	0.00	9.03	0.00	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.99	9.66	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	20.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.06	9.13	0.40	0.00	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	8.36	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.03	12.49	1.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.01	6.19	0.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	11.77	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.37	29.85	1.36	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	10.58	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.27	11.97	0.66	1.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.87	9.42	0.00	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	6.89	0.00	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.39	21.17	0.30	0.30	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.30	21.00	0.88	0.44	1.11	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	9.49	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	168.61	51.10	15.33	0.00	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	14.02	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.96	7.87	0.63	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.34	13.32	0.61	0.00	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	5.54	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	14.74	1.13	0.00	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	187.14	91.04	15.17	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	44.60	19.63	1.61	1.24	1.61	0.25	0.37
Myoblast, donor2	11322-117D8	48.33	25.70	2.88	0.96	0.77	0.77	0.00
Myoblast, donor3	11398-118D3	61.38	44.23	1.51	1.68	0.50	0.34	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	113.39	66.55	8.32	1.31	0.73	0.58	0.29
Natural Killer Cells, donor1	11230-116C6	42.74	36.59	3.38	3.38	0.31	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	32.87	31.66	3.92	1.51	0.30	1.81	0.30
Natural Killer Cells, donor3	11387-118C1	29.45	28.16	3.50	1.29	0.18	0.55	0.00
Neural stem cells, donor1	11275-116H6	65.33	46.09	3.27	1.45	0.00	1.45	0.36
Neural stem cells, donor2	11352-117H2	55.84	55.84	0.00	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	52.34	79.65	1.14	3.41	2.28	0.00	1.14
Neurons, donor2	11574-120E8	53.50	51.96	1.10	2.20	1.10	0.66	0.22
Neurons, donor3	11655-122E8	60.84	61.66	4.93	3.29	2.47	1.64	0.00
Neutrophils, donor1	11233-116C9	5.57	23.20	0.00	0.93	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	2.90	5.80	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.28	34.21	0.00	6.11	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	25.77	20.19	1.07	0.47	0.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	20.51	9.44	0.65	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	30.08	22.26	0.80	0.60	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.57	13.21	0.55	0.28	0.96	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	40.24	15.63	1.45	1.59	0.29	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	28.49	12.71	1.02	0.79	1.14	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	37.60	20.75	0.68	0.97	0.58	0.00	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	65.00	49.35	1.20	0.60	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.93	14.04	1.28	0.43	0.21	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	19.43	6.86	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	17.38	18.62	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	25.02	17.59	0.59	0.20	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	88.49	63.91	2.81	0.70	2.81	0.00	0.00
Osteoblast, donor3	11426-118G4	36.79	32.70	0.89	0.18	0.71	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	57.45	31.00	1.35	2.02	0.76	0.51	0.34
Pericytes, donor1	11491-119E6	5.79	4.01	0.22	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	6.56	9.28	0.23	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	16.07	13.63	0.20	0.20	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	49.28	53.23	0.90	1.02	0.45	0.34	0.11
Perineurial Cells, donor2	11579-120F4	53.46	29.08	1.56	0.92	0.83	0.55	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.61	51.95	4.46	1.59	0.32	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.24	24.73	2.94	1.71	0.73	0.98	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	20.58	29.77	3.11	1.04	0.00	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	23.68	21.76	0.00	0.48	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	27.72	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.74	22.58	0.00	0.20	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.15	11.71	0.00	0.32	0.95	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	24.57	10.88	0.75	0.38	0.75	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	24.28	15.66	0.13	0.78	0.52	0.52	0.13
Preadipocyte - breast, donor2	11328-117E5	27.69	17.11	1.13	0.68	0.00	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	30.26	14.28	0.32	0.53	0.43	0.11	0.21
Preadipocyte - omental, donor2	11329-117E6	48.88	26.62	1.75	0.00	1.75	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	42.40	17.91	0.57	0.72	0.57	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	24.61	16.73	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.33	11.98	0.31	0.31	0.61	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	116.16	63.57	4.96	1.95	0.71	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	67.43	32.35	2.55	0.85	0.51	1.02	0.34
Preadipocyte - visceral, donor1	11280-116I2	112.89	54.77	3.73	1.77	1.12	1.68	0.56
Preadipocyte - visceral, donor2	11357-117H7	80.07	23.93	2.76	0.92	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	99.89	42.84	2.72	1.15	0.42	1.15	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	130.03	53.40	1.96	1.06	0.30	1.36	0.00
Prostate Epithelial Cells, donor2	11331-117E8	20.72	12.32	0.14	0.27	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	10.29	19.90	0.49	0.73	0.12	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	84.63	38.04	1.37	2.96	1.37	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	92.16	39.09	1.08	2.33	0.36	1.79	0.00
Prostate Stromal Cells, donor3	11405-118E1	36.60	12.10	1.25	0.42	0.31	0.21	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	22.99	0.00	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.16	39.99	0.55	0.97	0.42	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	10.65	30.94	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.23	27.03	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	49.23	51.03	0.53	0.95	0.85	0.11	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	14.98	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	40.56	23.45	0.40	0.27	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	78.37	53.06	1.78	2.44	0.44	1.55	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	5.32	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.59	22.89	0.00	0.44	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	14.42	16.30	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.27	8.88	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	61.74	67.91	0.27	1.07	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.93	32.47	0.00	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.71	24.88	0.00	0.19	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	73.64	60.41	0.52	2.85	0.26	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.84	25.01	0.57	0.00	0.57	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	19.55	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.83	26.85	0.25	1.00	0.75	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	336.90	41.16	7.48	1.07	0.67	3.88	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	80.41	84.87	0.89	0.00	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	85.86	50.08	3.30	1.10	0.55	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	100.93	93.39	2.90	0.58	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	134.71	130.94	2.47	0.26	0.52	1.43	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	84.51	84.11	1.99	0.70	0.20	1.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	123.81	113.99	2.34	1.67	0.78	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	133.10	144.88	1.98	0.62	0.12	2.85	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	99.06	98.36	1.05	1.75	0.93	1.75	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	115.10	120.65	2.54	0.69	0.23	3.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	82.15	85.98	1.10	0.55	0.41	1.37	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.03	94.70	1.82	0.91	0.61	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	106.26	116.29	1.97	2.15	0.36	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	81.77	89.80	1.43	0.57	0.72	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	95.19	91.11	1.82	1.07	0.32	1.40	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	108.64	99.57	2.21	0.66	0.66	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	82.21	73.79	2.10	0.38	0.38	0.96	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	96.80	95.21	1.40	1.21	0.28	1.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	137.36	125.52	2.07	1.88	0.75	1.32	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	89.44	91.30	1.33	0.53	0.27	1.33	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	101.92	100.46	1.27	0.88	0.49	1.75	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	104.84	104.07	2.67	1.34	0.19	1.53	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	80.63	89.71	0.96	0.32	0.32	2.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	81.29	91.94	3.92	0.56	0.84	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	99.12	100.15	1.71	0.51	0.68	2.91	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	82.96	72.93	1.09	0.55	0.73	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	78.98	77.26	0.86	0.86	0.49	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	110.68	109.61	1.61	1.21	0.54	1.07	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	79.72	87.98	3.54	0.71	0.24	1.18	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	86.91	82.14	0.40	1.79	0.60	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	99.15	100.79	3.04	1.40	0.00	2.34	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	85.22	83.56	1.04	0.41	0.21	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	99.10	77.20	2.21	1.99	0.88	3.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	87.31	97.13	1.04	1.04	0.63	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	85.73	86.54	1.88	0.40	0.00	1.21	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	92.13	80.89	0.34	0.68	0.00	1.53	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	100.25	92.93	1.35	1.74	0.96	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	81.33	93.19	2.41	0.34	0.69	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.17	85.73	0.55	0.96	0.82	1.23	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	107.37	112.13	1.64	1.31	0.16	3.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	60.84	73.97	1.19	0.00	0.34	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	75.01	97.36	1.04	1.04	1.04	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	72.77	92.23	1.07	1.33	0.27	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	54.89	76.32	1.24	0.14	0.55	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	71.67	100.72	0.00	1.67	0.00	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	82.23	113.67	1.61	0.60	0.20	0.81	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	53.11	69.69	1.04	0.47	0.38	0.85	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	64.63	83.15	0.00	2.10	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	52.59	69.81	1.81	0.60	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	50.79	69.76	1.84	0.37	0.37	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	94.61	97.08	1.16	2.77	0.58	1.89	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	55.98	89.44	1.22	1.22	0.61	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	54.85	79.27	0.90	0.30	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	50.67	71.02	1.36	0.45	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.22	76.68	0.60	0.00	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	61.04	85.01	2.24	0.00	1.06	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	54.43	68.30	0.64	1.07	0.43	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.29	66.11	0.60	1.20	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	13.35	22.00	0.00	0.19	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	57.84	78.26	6.80	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	41.84	35.71	0.66	1.53	0.44	0.66	0.22
Sebocyte, donor1	11220-116B5	46.56	26.84	0.55	0.55	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	22.52	13.79	0.46	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	18.14	12.99	0.41	0.41	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	71.23	34.79	1.66	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	36.72	19.77	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.75	38.97	1.06	0.44	0.09	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.95	10.84	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	37.62	32.61	0.00	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	92.69	58.91	2.36	1.41	0.94	1.73	0.00
Skeletal Muscle Cells, donor5	11455-119A6	77.59	49.50	1.64	1.19	0.30	1.78	0.59
Skeletal Muscle Cells, donor6	11459-119B1	118.66	79.88	1.39	0.31	1.39	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.39	33.77	2.02	1.51	1.13	0.00	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.52	31.39	0.71	1.14	0.29	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	98.81	70.24	2.28	1.49	0.89	0.20	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	41.28	32.94	2.44	1.35	0.59	0.34	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	28.23	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.99	9.08	0.55	0.14	0.14	0.28	0.28
Skin - palm, donor1	10286-104F7	34.92	40.29	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.43	9.66	1.01	0.00	0.14	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.90	4.91	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.97	11.42	0.78	0.78	0.39	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	21.41	21.69	0.83	1.81	0.28	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	17.86	18.43	0.42	0.42	0.14	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	37.43	29.18	0.85	1.48	0.21	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	15.66	14.32	0.30	0.30	0.30	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.09	18.21	0.31	0.62	0.00	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.56	11.56	0.89	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.74	17.63	0.00	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.96	13.70	0.88	0.22	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.23	11.42	1.97	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	24.72	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	20.02	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.68	14.90	0.80	0.27	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	45.00	17.29	1.99	1.33	0.44	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	41.74	18.69	0.90	0.38	0.77	0.51	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	50.79	26.70	0.98	1.63	0.98	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	50.80	36.92	2.36	0.89	0.30	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.30	20.36	0.28	0.57	0.14	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.22	11.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.00	15.83	0.91	0.91	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.32	15.41	0.25	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	15.26	0.48	0.00	0.00	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.25	19.91	0.44	0.59	0.15	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.22	19.37	1.29	0.43	0.22	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	49.02	32.64	0.42	0.63	0.52	0.73	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.28	15.31	0.31	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	9.70	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	37.36	19.43	1.49	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.34	16.05	0.00	0.34	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	34.24	15.47	1.81	0.94	1.02	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	44.18	17.11	1.41	1.41	0.20	0.50	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.43	20.93	1.59	0.00	0.00	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	19.93	9.66	0.00	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	173.26	113.92	1.85	7.15	2.12	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.31	36.09	2.00	0.40	0.40	0.80	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	44.45	16.28	1.50	0.63	0.38	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.83	14.21	1.01	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	75.69	33.92	1.51	1.51	0.60	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.01	11.25	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	32.31	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.69	21.39	1.40	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.84	13.63	0.00	0.00	1.01	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	24.13	9.40	0.31	0.00	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.78	6.19	0.00	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	128.38	81.22	1.08	2.58	1.50	0.25	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	30.37	14.01	1.87	0.47	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.59	14.10	0.43	0.14	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.89	19.63	1.27	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.15	21.25	0.19	0.00	0.00	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	66.94	60.23	1.12	1.96	0.70	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	35.78	25.39	0.42	1.01	0.34	0.25	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	2.38	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.37	14.68	0.00	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	48.61	19.44	1.10	0.88	0.66	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	88.36	40.08	2.34	2.63	0.59	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.82	14.77	0.78	0.78	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	39.14	11.11	0.26	0.26	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	25.29	5.21	1.12	1.12	1.12	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	28.39	10.06	1.44	0.36	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	34.35	17.89	0.57	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	87.04	57.50	1.18	3.54	0.79	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	33.78	11.17	1.52	0.76	0.51	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	24.36	13.18	0.00	0.80	1.60	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	39.71	12.12	1.25	1.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.50	17.88	0.92	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	33.83	20.20	2.19	1.51	1.01	0.17	0.34
Synoviocyte, donor2	11368-117I9	45.43	16.09	0.67	0.67	0.50	0.34	0.00
Synoviocyte, donor3	11440-118H9	45.13	15.19	1.12	0.45	0.45	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	36.81	34.66	0.36	0.71	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	25.77	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.04	21.30	0.00	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	30.11	34.41	0.43	1.00	0.43	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	22.81	14.30	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	24.05	11.45	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	338.56	44.29	9.10	1.11	0.74	5.17	0.12
Urethra, donor2	10319-105A4	32.37	28.77	0.00	1.80	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	6.91	9.30	0.27	0.53	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	3.20	8.41	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.65	6.19	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	20.06	22.29	0.89	1.11	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	25.80	84.53	4.45	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	84.35	2.86	0.00	1.43	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	32.86	2.74	0.68	0.00	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.69	49.24	3.79	0.34	0.69	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.24	43.58	3.49	0.58	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	33.32	49.98	1.04	0.00	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	57.82	3.67	0.92	2.75	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.91	19.17	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	108.56	41.45	2.22	2.10	0.62	1.23	0.25
Wilms' tumor cell line:HFWT	10597-108E3	95.04	81.84	0.00	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	129.32	85.75	1.40	7.54	2.23	0.00	0.56
achilles tendon, donor2	10292-104G4	39.26	24.80	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	301.87	190.45	17.34	4.33	2.29	8.16	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	209.89	156.95	4.41	9.52	2.79	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	136.87	88.20	2.85	3.21	0.95	1.42	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	340.14	136.87	9.25	5.71	1.90	5.99	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	293.45	102.88	13.21	5.62	1.41	3.37	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	106.16	107.01	9.09	3.81	1.27	2.33	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	71.05	73.50	6.26	2.18	1.36	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	189.03	61.69	14.54	0.88	0.88	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	85.35	77.18	8.17	1.23	0.00	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	153.77	77.66	7.38	1.94	1.16	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	154.56	98.44	24.10	6.62	2.39	7.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	46.81	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	183.12	64.14	18.82	2.09	0.23	1.86	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	160.00	91.39	12.95	3.88	2.59	2.07	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	161.61	81.54	19.00	4.38	2.34	2.63	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	78.54	67.85	5.11	1.86	1.39	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	97.06	58.40	5.76	4.52	0.00	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	147.34	82.88	4.91	2.46	0.61	1.84	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	233.41	95.16	24.32	4.69	2.13	8.53	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	224.74	83.10	29.42	4.55	2.43	9.40	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	236.85	101.58	23.35	4.57	3.61	8.67	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	262.83	95.55	11.36	4.23	2.23	2.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	132.75	116.41	3.67	3.00	2.00	0.67	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	419.95	222.98	5.57	0.00	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	205.66	96.80	10.17	5.27	0.75	3.01	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	105.98	94.64	4.80	0.87	1.74	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	114.34	93.72	3.75	1.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	102.91	23.31	1.41	0.00	0.94	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	43.12	30.71	2.17	1.09	0.47	0.16	0.47
adipose, donor1	10184-103D4	239.84	185.31	4.69	4.10	1.17	1.76	0.00
adipose, donor2	10185-103D5	38.93	44.61	0.00	0.41	0.41	0.00	0.00
adipose, donor3	10186-103D6	65.35	56.64	0.82	0.82	1.36	1.36	0.00
adipose, donor4	10187-103D7	103.14	117.88	3.47	0.87	2.60	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	110.95	69.76	0.95	0.63	0.47	0.63	0.32
adrenal gland, adult, pool1	10081-102A9	10.91	25.46	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	135.67	122.47	2.40	2.27	0.53	1.33	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	140.42	61.46	2.50	0.71	1.43	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	64.22	71.18	0.46	2.09	1.16	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	74.72	81.82	1.69	2.03	2.03	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	49.79	64.52	0.59	0.29	0.59	0.00	0.59
amygdala - adult, donor10196	10167-103B5	161.27	53.36	20.16	0.00	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	117.00	55.15	5.47	3.24	0.81	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	214.00	37.76	20.66	5.49	1.61	1.94	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	21.65	28.27	0.13	0.13	0.13	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	296.08	119.36	5.52	3.97	3.09	1.10	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.51	58.79	2.34	0.67	0.00	1.67	0.00
aorta, adult, pool1	10052-101G7	44.13	21.18	0.98	0.59	0.00	0.20	0.20
appendix, adult	10189-103D9	63.26	60.93	3.10	0.78	0.78	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	129.66	80.82	2.75	1.38	1.03	1.03	0.00
artery, adult	10190-103E1	32.61	43.48	0.00	5.43	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	66.64	82.43	0.87	1.74	1.30	0.72	0.29
b cell line:RPMI1788	10427-106D4	80.74	62.60	8.92	1.64	0.59	2.38	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	48.00	29.41	0.83	1.11	0.28	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	116.60	108.76	2.08	3.37	1.39	0.50	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	18.08	33.64	0.00	2.51	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	55.92	49.21	11.18	1.68	0.56	1.12	0.00
bladder, adult, pool1	10011-101C2	36.39	38.24	1.85	0.76	0.11	0.43	0.43
blood, adult, pool1	10053-101G8	15.50	17.72	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	88.20	53.09	0.00	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	30.37	33.07	4.72	0.00	1.35	0.67	0.00
brain, adult, donor1	10084-102B3	45.10	28.70	2.05	4.10	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	95.32	64.25	5.46	3.01	1.22	2.23	0.00
brain, fetal, pool1	10085-102B4	48.09	26.71	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	123.23	56.16	3.63	1.32	1.98	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	102.48	69.03	2.12	1.00	0.87	0.37	0.25
breast, adult, donor1	10080-102A8	152.79	22.10	0.63	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	136.06	60.85	1.40	4.57	1.91	0.51	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.71	59.37	0.93	1.86	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.45	39.60	0.69	0.92	0.23	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	139.93	58.10	1.69	1.45	0.24	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	152.33	160.80	2.82	2.82	1.41	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	49.44	51.74	0.44	0.55	0.33	0.33	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	199.96	72.25	6.02	1.58	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	111.53	93.43	5.32	2.40	1.60	2.40	0.00
caudate nucleus - adult, donor10196	10177-103C6	102.47	42.60	16.12	2.30	1.15	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	134.36	48.86	13.55	3.85	0.17	1.84	0.67
caudate nucleus, adult, donor10258	10379-105H1	113.86	29.80	22.16	1.53	1.53	3.82	0.76
caudate nucleus, newborn, donor10223	10354-105E3	261.49	44.31	18.31	10.25	1.46	2.93	0.73
cerebellum - adult, donor10196	10173-103C2	122.36	119.44	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	159.28	135.37	1.71	2.56	0.21	0.64	0.00
cerebellum, adult, pool1	10083-102B2	57.26	55.19	3.45	2.41	0.34	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	72.23	38.19	7.47	2.49	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	141.70	67.83	9.08	3.03	0.76	2.02	0.25
cerebrospinal fluid, donor2	10294-104G6	40.20	34.35	2.19	2.19	0.00	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	101.51	44.43	3.02	2.01	0.58	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	39.77	36.29	0.66	1.33	0.17	0.17	0.33
cervix, adult, pool1	10013-101C4	34.44	44.41	1.47	1.05	0.42	0.10	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	77.61	59.22	0.98	1.81	0.98	0.70	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	39.19	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	161.31	122.91	2.36	3.85	1.12	1.24	0.50
choriocarcinoma cell line:SCH	10785-110H2	76.02	46.45	0.86	1.72	1.72	0.37	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	155.11	71.63	2.13	0.24	0.47	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	42.17	35.61	1.71	0.28	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	55.98	29.93	0.50	1.09	0.99	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	58.25	37.36	1.65	0.55	0.00	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	184.79	83.81	13.13	6.06	1.01	6.06	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	212.27	99.31	12.87	2.11	0.58	3.65	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	134.53	102.85	4.65	1.27	0.21	1.06	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	187.72	102.46	2.31	10.27	4.37	0.26	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	208.98	106.18	3.14	10.88	2.90	0.97	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	183.45	87.35	3.87	8.14	2.65	0.41	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	532.38	149.58	4.42	9.72	4.71	0.88	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	141.52	109.46	3.13	3.65	1.04	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	149.49	95.32	0.91	0.91	0.23	1.60	0.23
clear cell carcinoma cell line:TEN	10636-108I6	108.96	29.67	1.04	1.21	1.74	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	168.03	74.13	0.92	2.93	1.28	1.83	0.37
colon carcinoma cell line:COLO-320	10420-106C6	100.72	80.96	1.90	2.28	0.38	0.38	0.38
colon, adult, donor1	10082-102B1	40.46	20.23	0.00	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	36.19	32.55	1.06	0.82	0.94	0.59	0.24
colon, fetal, donor1	10070-101I7	32.75	28.43	1.24	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	68.75	192.51	0.00	9.17	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	75.11	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	181.87	55.24	38.67	2.55	0.85	5.95	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	178.25	72.30	25.36	1.36	1.66	3.17	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	195.02	87.29	26.79	1.97	1.55	3.81	0.56
corpus callosum, adult, pool1	10042-101F6	39.47	57.49	1.00	1.66	0.66	0.33	0.00
cruciate ligament, donor2	10295-104G7	27.56	26.75	0.81	1.62	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	44.94	38.52	0.80	0.80	0.80	0.00	0.00
diencephalon, adult	10193-103E4	85.68	55.44	6.72	3.12	0.48	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	193.79	164.40	11.71	6.20	2.30	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	116.68	53.08	1.54	1.80	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	103.51	36.11	1.69	2.89	0.48	0.72	0.24
ductus deferens, adult	10196-103E7	45.85	36.38	0.50	3.49	2.49	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	38.89	2.88	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.82	46.35	1.47	1.47	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	26.18	29.57	2.31	1.82	0.33	0.50	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	47.75	49.97	2.22	4.89	5.33	0.00	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	120.94	88.41	2.87	3.73	4.30	0.29	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	78.93	59.81	1.23	0.62	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	72.05	25.73	0.61	0.30	0.30	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	83.36	44.77	0.00	1.23	0.62	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	124.78	72.24	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	74.75	72.07	1.01	1.68	0.67	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	98.59	78.11	0.18	1.45	0.18	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	128.97	57.57	0.80	1.61	0.16	0.80	0.00
epidermoid carcinoma cell line:A431	10426-106D3	93.37	78.70	1.11	2.11	0.44	0.33	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	143.53	87.11	1.76	3.63	0.99	0.44	0.11
epididymis, adult	10197-103E8	28.05	31.40	1.26	1.26	0.63	0.00	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.48	61.21	0.18	0.89	0.35	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	73.93	12.58	1.97	1.18	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	288.70	97.24	3.54	5.50	2.62	3.80	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	172.53	72.44	3.74	3.44	2.07	1.67	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	290.27	91.08	4.15	4.93	2.80	2.80	0.90
esophagus, adult, pool1	10015-101C6	40.56	33.55	1.06	0.85	0.74	0.21	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.22	25.92	1.38	1.63	0.50	0.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	24.15	19.32	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	37.88	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	37.21	41.67	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	30.96	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	48.09	16.03	0.00	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	37.12	51.36	0.76	1.27	0.76	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	79.11	61.03	0.77	1.54	0.51	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	127.73	75.74	1.90	0.47	0.95	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	135.01	83.22	7.88	3.94	2.06	1.03	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	80.47	89.77	0.90	2.10	3.00	0.00	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	55.78	41.33	0.27	1.74	0.27	0.37	0.09
gall bladder, adult	10198-103E9	29.21	27.76	0.72	0.97	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	32.21	66.03	3.76	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	48.18	54.90	2.99	1.87	0.37	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	70.97	20.91	1.48	1.06	0.42	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	88.39	72.92	0.58	1.35	0.58	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	144.94	70.34	2.30	2.30	1.31	0.16	0.49
gastric cancer cell line:GSS	10560-108A2	98.84	66.81	2.75	0.00	1.83	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	117.88	79.05	4.11	1.14	0.00	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	67.93	80.32	0.34	1.38	0.92	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	106.23	65.36	0.56	2.10	0.28	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	110.49	56.87	1.25	0.00	0.00	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	95.10	51.51	2.64	2.11	0.84	0.53	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	110.10	57.86	1.69	1.54	1.69	0.56	0.14
glioblastoma cell line:T98G	10485-107A8	132.67	48.01	3.09	2.65	1.10	0.33	0.77
glioma cell line:GI-1	10413-106B8	107.49	67.07	2.93	1.17	1.17	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	96.22	45.92	1.46	2.19	2.19	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	125.95	93.73	5.86	2.20	0.24	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	38.34	32.86	5.48	4.11	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	138.03	29.84	2.66	3.20	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	144.38	352.39	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	43.71	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	67.95	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.64	26.56	0.00	1.28	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	121.21	128.09	0.46	2.30	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	122.55	114.77	1.83	1.83	1.37	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	137.84	144.28	0.64	3.22	2.58	0.00	0.00
hIPS, biol_rep1	14380-156B6	160.98	143.73	4.31	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	118.66	148.15	2.06	2.06	0.69	0.00	1.37
hIPS, biol_rep3	14382-156B8	110.35	78.35	8.83	3.31	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	67.24	78.44	4.31	0.86	0.00	0.57	0.00
heart - mitral valve, adult	10205-103F7	57.40	27.21	0.60	2.09	0.30	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	29.55	37.65	0.52	0.26	0.00	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	168.19	29.14	0.83	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	40.81	33.26	0.61	0.41	0.20	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	9.37	23.85	0.00	0.85	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	32.89	46.00	0.00	0.00	0.00	0.00	0.46
heart, fetal, pool1	10046-101G1	46.31	57.71	0.21	0.72	0.41	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.38	24.06	0.62	0.00	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	283.02	121.30	2.38	1.19	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	151.38	76.24	2.87	1.99	1.22	1.77	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	168.95	72.46	3.03	1.70	1.58	1.58	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	163.20	73.67	3.33	2.83	1.41	2.02	1.01
hepatoma cell line:Li-7	10484-107A7	65.17	32.59	0.33	1.45	0.33	0.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	152.26	113.06	5.63	3.82	1.81	2.11	0.60
hippocampus - adult, donor10196	10169-103B7	148.57	53.94	7.57	0.95	0.00	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	106.54	64.70	4.08	2.25	1.02	0.82	0.41
hippocampus, adult, donor10258	10374-105G5	97.10	61.25	8.96	1.49	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	121.96	22.56	7.05	1.76	0.35	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	191.65	233.15	3.05	15.87	1.22	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	106.23	130.77	1.96	5.89	0.98	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	115.01	155.89	1.52	7.87	2.29	0.00	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	53.57	65.97	1.13	1.69	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	73.59	63.26	1.81	2.84	0.26	1.55	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.77	72.13	1.14	1.14	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	59.27	52.26	2.63	0.88	0.58	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.86	46.10	1.08	2.59	0.22	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	64.65	48.80	0.42	1.25	0.00	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.17	79.09	0.95	1.89	2.37	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	63.80	61.88	1.77	2.41	0.80	0.96	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	71.37	86.86	1.35	6.06	0.00	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	93.26	113.76	1.72	5.63	1.56	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	111.03	132.65	1.97	6.88	0.00	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	126.55	174.55	0.87	10.47	1.75	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	74.26	72.55	0.95	2.67	0.19	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	78.06	54.51	1.74	1.74	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	99.45	85.96	2.00	2.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.81	36.17	2.64	1.88	0.19	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	33.19	43.20	0.91	2.27	0.00	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.53	44.48	1.88	0.63	0.31	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	45.23	40.34	1.31	0.65	0.33	0.33	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.61	41.51	1.45	1.16	0.29	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	42.15	44.84	1.49	0.30	0.60	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	120.45	117.68	0.74	4.43	1.11	1.11	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	109.26	113.83	0.29	3.14	0.86	0.57	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	182.92	193.95	2.04	11.43	0.82	2.04	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	87.67	71.82	1.06	2.11	0.00	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	63.03	65.25	1.27	1.58	0.95	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	65.37	64.16	1.82	1.82	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	45.51	37.75	2.59	1.55	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	36.53	43.17	5.31	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.07	44.12	2.31	1.28	0.00	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	67.24	51.90	2.30	0.51	0.00	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	63.61	57.55	1.51	0.00	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	64.19	56.79	0.34	3.70	0.00	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	106.50	121.24	0.97	5.31	1.69	0.97	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	123.45	165.79	1.34	8.47	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	115.61	129.76	0.49	5.37	0.98	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	68.15	70.60	1.83	2.14	0.00	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	380.63	354.60	9.76	13.01	0.00	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	89.02	87.37	2.32	3.64	0.00	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.78	53.64	1.09	1.09	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	34.02	35.46	1.09	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	46.62	38.79	3.91	1.07	1.42	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	48.93	34.61	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	70.69	71.78	1.76	2.44	0.95	0.68	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	54.96	47.95	1.35	1.35	0.54	1.08	0.54
immature langerhans cells, donor1	11904-125F5	21.07	29.30	13.80	0.73	0.24	1.45	0.00
immature langerhans cells, donor2	11905-125F6	13.47	24.56	6.34	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	117.82	72.21	6.06	1.80	1.14	1.99	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	83.89	27.64	0.65	2.28	0.33	0.33	0.33
kidney, adult, pool1	10017-101C8	58.98	40.35	1.10	1.90	1.20	0.20	0.40
kidney, fetal, pool1	10045-101F9	46.54	35.01	0.71	0.21	0.00	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	47.01	27.55	0.57	0.71	0.14	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	73.13	39.40	1.66	1.11	0.41	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	81.47	58.54	0.18	1.47	0.18	0.00	0.37
left atrium, adult, donor1	10079-102A7	21.25	15.26	0.54	2.18	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	21.24	18.20	0.00	0.51	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	93.85	42.68	0.82	0.55	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	40.95	11.86	0.72	1.08	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	33.15	10.87	0.54	1.09	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	57.55	17.97	1.21	1.21	0.49	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	19.05	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	72.14	31.37	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	82.52	39.79	2.83	0.94	0.24	0.59	0.00
liposarcoma cell line:KMLS-1	10782-110G8	52.33	22.18	1.09	0.62	0.16	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	55.07	26.20	0.85	1.10	0.49	0.24	0.00
liver, adult, pool1	10018-101C9	34.19	16.69	0.49	0.97	0.65	0.00	0.81
liver, fetal, pool1	10086-102B5	48.92	12.23	1.88	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	77.72	49.73	2.04	3.65	0.87	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	127.52	83.60	2.21	3.14	1.11	1.29	0.18
locus coeruleus, adult, donor10258	10375-105G6	64.05	33.57	1.13	3.95	0.85	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	160.68	40.80	7.15	2.94	1.26	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	45.95	46.09	0.42	1.94	1.38	0.00	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	68.25	68.25	0.69	1.38	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	48.77	54.84	0.40	0.79	0.26	0.40	0.13
lung, adult, pool1	10019-101D1	40.87	22.09	2.24	0.83	0.35	0.71	0.12
lung, fetal, donor1	10068-101I5	105.89	63.08	3.42	1.43	1.14	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	39.41	24.29	3.67	0.46	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	24.14	28.88	1.89	0.47	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	144.22	113.97	3.95	6.79	1.75	1.53	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	142.32	119.08	8.75	1.66	0.91	3.17	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.02	45.02	0.85	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	59.05	74.15	0.00	2.22	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	47.94	50.43	0.00	2.28	2.28	0.00	0.00
mature adipocyte, donor3	12233-129G1	47.89	41.01	0.24	0.71	0.95	0.24	0.24
mature adipocyte, donor4	12234-129G2	80.81	62.91	1.58	1.05	0.26	0.53	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	90.78	95.78	1.43	1.91	1.19	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	163.56	101.52	13.54	6.77	1.13	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	114.57	69.15	6.07	4.41	0.74	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	131.52	87.68	6.99	1.27	1.91	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	406.87	41.37	28.57	13.65	1.71	7.68	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	165.71	77.96	8.94	4.05	1.86	1.52	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	119.48	67.70	2.76	3.61	0.85	1.06	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	111.72	69.35	17.34	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1062.17	315.78	71.77	28.71	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	201.00	28.36	10.05	4.31	0.00	1.79	0.00
medulla oblongata - adult, donor10196	10174-103C3	66.84	47.38	0.65	1.30	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	132.20	81.74	2.17	1.39	0.62	0.93	0.77
medulla oblongata, adult, pool1	10038-101F2	61.96	58.45	1.39	1.71	1.47	0.33	0.33
medulla oblongata, newborn, donor10223	10361-105F1	104.50	48.61	2.43	1.74	0.35	1.74	0.69
medulloblastoma cell line:D283 Med	10838-111E1	170.27	128.86	0.44	2.44	1.33	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	182.55	83.27	2.45	2.57	0.73	1.10	0.37
melanoma cell line:COLO 679	10514-107E1	36.94	33.92	0.43	3.45	1.72	0.29	0.72
melanoma cell line:G-361	10465-106H6	38.82	19.00	2.17	1.09	0.00	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	65.67	27.50	0.90	0.18	0.00	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	200.02	102.21	1.76	1.76	0.88	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	113.54	80.88	2.33	4.67	0.26	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	84.08	33.91	3.22	1.07	0.77	1.23	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.44	29.08	2.18	0.18	0.55	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	68.33	19.46	4.14	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	53.38	19.25	1.97	0.84	0.28	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	52.19	21.18	2.70	1.16	0.19	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.79	22.21	1.39	0.69	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.38	29.18	0.51	0.86	0.34	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	57.62	22.89	1.61	0.92	0.23	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	74.28	29.45	1.99	0.66	0.53	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	101.55	44.29	1.62	0.41	0.68	1.08	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	84.22	41.68	1.00	0.43	0.57	0.28	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.26	23.38	0.99	1.32	0.33	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	53.83	27.95	2.08	0.42	0.42	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	93.90	33.51	0.70	0.70	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.61	34.10	1.22	0.61	0.20	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	16.53	0.00	0.36	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.59	26.69	0.72	0.10	0.41	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.45	14.36	0.23	0.91	0.46	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	139.71	74.26	2.52	0.84	0.00	2.52	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	54.40	27.94	0.45	0.00	0.45	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	53.74	32.74	1.58	0.26	0.44	0.35	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	56.33	38.29	1.84	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	17.17	0.29	0.00	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	102.31	74.10	2.53	2.53	0.42	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	46.58	19.18	0.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	35.55	18.67	0.77	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	40.31	20.68	1.57	1.31	0.52	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.66	19.41	0.31	0.62	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.24	19.53	0.94	0.24	0.71	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	38.58	23.02	1.35	0.68	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.12	23.19	0.00	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.27	21.78	0.93	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	43.55	26.53	0.58	0.87	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.15	19.63	0.89	0.45	0.00	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	35.33	18.27	0.96	0.72	0.72	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.13	23.47	0.73	0.73	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.89	15.78	1.68	2.35	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	36.43	19.65	0.41	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	42.96	18.90	0.43	2.15	0.00	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	21.88	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	30.99	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	37.68	19.81	0.32	1.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	45.10	13.09	0.00	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	41.58	21.32	1.07	0.53	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	40.07	22.08	2.45	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	37.71	17.10	0.78	1.17	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	35.68	20.99	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	42.72	14.90	1.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	19.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	20.16	0.59	0.00	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	42.65	24.37	0.00	1.22	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	29.14	13.93	1.90	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.84	12.07	1.72	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	15.04	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	13.78	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.67	10.19	0.00	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.96	11.92	4.77	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.12	9.43	1.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	23.69	18.08	0.94	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	18.71	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	34.30	14.19	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	77.04	25.68	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	43.37	21.34	1.38	0.69	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	93.52	32.16	1.48	0.00	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	84.11	28.04	1.12	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	73.15	36.26	1.27	1.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	87.45	57.22	0.40	0.81	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	100.31	47.97	0.00	2.18	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	67.15	45.61	0.00	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	64.33	44.91	0.61	0.61	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	90.38	72.30	0.00	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	70.84	36.24	0.82	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.55	26.79	0.60	0.60	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	51.92	23.36	0.32	0.00	1.30	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	38.71	25.47	2.04	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.17	33.27	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	92.37	85.52	0.24	0.71	1.18	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.48	29.42	1.16	0.93	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	188.04	55.56	4.27	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	160.91	36.99	3.49	1.44	0.62	1.64	0.21
mesothelioma cell line:Mero-25	10850-111F4	54.70	40.85	0.00	1.59	0.23	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	184.33	69.19	4.89	2.93	0.49	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	110.27	39.41	1.77	0.44	0.66	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	48.36	29.96	1.31	2.10	0.00	1.31	0.00
mesothelioma cell line:Mero-83	10854-111F8	92.60	30.98	2.21	0.68	0.00	0.51	0.34
mesothelioma cell line:Mero-84	10855-111F9	91.76	43.98	0.25	1.01	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	90.68	27.74	2.69	1.86	1.04	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	41.58	14.41	0.66	0.00	0.17	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	159.45	36.38	7.60	1.63	1.81	1.27	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	119.23	37.07	1.54	1.88	1.20	1.88	0.34
mesothelioma cell line:NCI-H28	10845-111E8	81.94	102.30	2.04	3.31	3.05	0.51	0.76
mesothelioma cell line:No36	10857-111G2	174.84	64.91	3.26	2.94	1.30	0.65	0.98
mesothelioma cell line:ONE58	10858-111G3	104.86	36.04	1.90	1.63	0.54	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	122.64	49.52	7.29	0.38	0.00	1.15	0.00
migratory langerhans cells, donor2	11902-125F3	84.75	44.08	3.91	0.61	0.61	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	121.33	76.64	16.69	0.54	0.18	2.33	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	77.38	32.65	0.65	0.65	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	79.26	33.49	0.64	0.85	0.21	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	61.28	48.38	0.00	1.15	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.18	48.52	7.23	0.95	0.76	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	318.03	184.05	34.93	6.65	2.77	7.21	1.11
myeloma cell line:PCM6	10474-106I6	25.89	31.82	0.59	0.79	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	107.04	52.25	1.01	1.01	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	77.87	40.60	1.37	1.77	0.39	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.83	25.96	0.11	0.33	0.33	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.13	23.24	0.44	1.25	0.37	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	21.53	29.81	0.55	1.10	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	87.19	108.59	3.68	1.61	0.46	0.23	1.15
neuroblastoma cell line:NB-1	10539-107G8	315.43	311.31	9.35	6.17	2.06	4.68	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	88.78	46.61	1.27	0.84	0.84	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	100.63	95.04	0.75	2.05	0.75	0.93	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	102.72	47.68	16.37	1.66	0.47	3.32	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	69.53	23.28	2.06	1.11	0.63	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	114.32	60.58	3.02	2.21	2.42	0.20	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	179.29	59.76	3.81	0.64	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	51.10	22.62	0.27	0.27	0.27	0.00	0.80
neutrophil PMN, donor1	12133-128D9	0.00	267.75	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	53.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	197.53	201.25	10.99	4.06	1.52	2.88	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	378.64	162.50	8.01	1.60	1.60	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	48.41	19.24	1.60	0.00	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.83	20.76	1.05	0.79	0.53	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	113.05	69.09	10.31	2.44	1.41	1.22	0.47
occipital cortex - adult, donor10196	10172-103C1	166.89	70.05	14.42	8.24	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	111.10	66.29	4.03	1.34	0.81	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	192.89	30.57	12.74	5.82	1.09	2.55	0.00
occipital lobe, adult, donor1	10076-102A4	112.83	69.80	6.56	3.94	1.05	0.26	0.79
occipital lobe, fetal, donor1	10073-102A1	73.81	36.47	2.57	1.72	0.00	2.57	0.43
occipital pole, adult, pool1	10036-101E9	67.65	50.62	1.89	1.10	0.39	0.39	0.47
olfactory region, adult	10195-103E6	81.96	59.42	5.92	2.67	1.53	1.72	0.19
optic nerve, donor1	10277-104E7	54.03	56.03	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	83.72	26.65	0.68	2.39	1.03	0.11	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	316.26	86.97	1.24	4.67	1.79	0.82	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	62.48	35.39	0.85	1.69	0.51	0.34	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	50.02	34.19	1.62	1.27	0.69	0.46	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	31.75	32.92	0.29	0.00	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	131.74	135.48	0.93	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	152.68	65.53	0.85	0.64	0.42	1.27	0.21
ovary, adult, pool1	10020-101D2	47.78	46.91	1.48	1.40	0.44	0.17	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.58	30.98	0.18	0.92	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	24.46	29.16	0.00	0.94	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	104.27	48.36	1.68	0.84	0.28	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	81.26	40.03	2.04	2.38	0.68	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.65	33.28	1.66	1.66	0.17	0.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	108.00	79.81	4.85	2.01	1.28	0.64	0.46
parietal cortex, adult, donor10258	10373-105G4	77.07	43.31	11.01	0.73	1.47	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	131.67	78.06	7.52	3.76	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	118.86	66.98	5.13	2.85	0.86	0.29	1.43
parietal lobe, adult, pool1	10034-101E7	103.28	73.40	3.08	1.50	0.62	1.32	0.18
parietal lobe, fetal, donor1	10072-101I9	74.68	51.40	3.88	0.97	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	226.93	31.03	19.81	5.61	0.75	3.36	0.37
parotid gland, adult	10199-103F1	37.00	34.53	0.00	0.00	0.00	0.00	0.62
penis, adult	10200-103F2	37.06	26.86	1.61	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	249.71	45.37	3.16	1.12	0.37	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	52.30	40.65	0.87	2.19	0.44	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	21.29	25.16	0.00	1.94	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	78.17	68.10	0.59	3.55	1.78	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	31.98	26.34	1.25	4.39	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	42.50	62.73	1.01	4.05	6.07	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	85.47	126.65	2.08	5.21	5.21	0.52	2.08
pituitary gland, adult, donor10258	10378-105G9	38.31	55.33	0.85	1.70	2.55	0.00	0.85
placenta, adult, pool1	10021-101D3	39.02	27.31	0.43	1.29	1.18	0.22	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	73.63	59.33	4.24	1.06	0.79	0.53	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	51.36	55.41	0.78	1.71	0.78	0.16	0.31
pons, adult, pool1	10033-101E6	130.82	91.23	4.39	4.13	1.81	1.03	1.03
postcentral gyrus, adult, pool1	10032-101E5	92.93	65.21	3.84	2.09	0.87	0.78	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	209.14	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	22.03	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	109.97	75.31	0.58	3.20	1.60	0.15	0.58
prostate cancer cell line:PC-3	10439-106E7	94.20	56.99	0.91	2.00	0.54	0.18	0.36
prostate, adult, pool1	10022-101D4	57.68	54.42	0.91	0.54	0.54	0.18	0.45
putamen, adult, donor10196	10176-103C5	156.98	44.85	22.90	4.72	1.42	2.83	0.94
putamen, adult, donor10252	10152-102I8	145.09	72.55	7.84	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	110.37	73.22	19.67	1.09	1.09	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	92.78	30.68	12.81	2.42	0.24	1.45	0.72
putamen, newborn, donor10223	10365-105F5	295.37	27.74	16.49	5.25	0.75	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	61.68	48.59	0.00	0.58	1.16	0.58	0.29
rectum, fetal, donor1	10067-101I4	68.16	36.17	2.78	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	62.96	52.58	0.64	1.06	1.06	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.27	48.05	0.83	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	28.03	38.77	0.80	1.19	0.40	0.50	0.20
retinoblastoma cell line:Y79	10475-106I7	269.41	202.65	4.94	3.38	2.60	0.78	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	103.40	42.79	1.11	0.49	0.74	0.25	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	125.70	134.13	0.84	1.97	1.69	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.92	21.22	2.27	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	29.30	18.29	1.78	0.16	0.16	0.16	0.16
salivary acinar cells, donor2	11772-123I8	22.99	15.70	0.55	0.28	0.83	0.14	0.14
salivary acinar cells, donor3	11773-123I9	21.85	23.17	0.66	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	30.31	33.17	2.29	0.00	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	105.98	41.23	2.95	1.43	1.26	0.59	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	121.20	45.85	2.12	0.94	1.06	1.06	0.24
seminal vesicle, adult	10201-103F3	37.56	33.86	1.06	0.53	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	57.57	53.69	0.73	4.86	2.19	0.73	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	55.61	62.66	0.25	0.75	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	109.39	92.33	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	75.89	25.66	1.48	0.81	0.67	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	46.64	19.01	0.99	2.10	0.55	0.88	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	116.90	51.74	1.94	1.94	1.81	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	35.47	43.98	0.00	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	26.87	39.58	0.24	1.08	0.60	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	27.14	26.13	3.02	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	56.81	46.08	1.89	1.26	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	124.40	93.05	0.00	1.00	0.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	135.85	54.85	2.21	3.47	1.26	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	154.39	115.26	0.77	2.89	0.58	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	209.83	131.70	2.64	1.98	0.99	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	77.37	214.73	0.80	3.22	2.25	0.64	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	105.04	61.67	2.18	1.74	0.65	1.31	0.65
small intestine, adult, pool1	10024-101D6	43.60	44.79	1.79	0.60	0.72	0.48	0.60
small intestine, fetal, donor1	10064-101I1	42.01	37.10	1.23	1.72	0.74	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	114.38	29.24	3.59	1.54	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	30.24	32.05	1.03	0.52	0.00	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	49.85	33.77	0.80	0.27	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	63.55	50.01	1.61	2.75	1.38	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	123.01	80.83	2.37	1.58	1.18	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	58.11	69.18	3.46	0.69	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	65.86	58.54	1.83	1.22	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	168.99	75.31	3.21	5.05	2.30	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	52.72	30.92	0.45	0.90	1.05	0.15	0.15
spleen, adult, pool1	10025-101D7	39.21	35.46	2.31	1.98	0.99	0.55	0.55
spleen, fetal, pool1	10044-101F8	69.05	31.31	2.22	0.48	0.48	0.56	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	105.69	73.39	10.45	1.35	0.62	2.17	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	64.75	46.52	0.95	1.71	0.57	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	102.74	60.80	1.40	1.75	0.70	1.40	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	40.27	30.88	0.39	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	49.53	20.94	0.23	1.80	0.56	0.23	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	182.15	133.86	0.85	3.39	0.85	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	150.61	81.23	0.85	2.96	1.69	0.00	0.42
stomach, fetal, donor1	10062-101H8	36.31	26.70	2.14	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	27.34	41.59	1.14	0.57	0.57	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	162.82	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	127.12	97.21	1.87	2.28	0.21	1.04	0.00
substantia nigra, adult, donor10258	10371-105G2	89.48	78.62	6.21	0.00	2.59	0.00	1.55
substantia nigra, newborn, donor10223	10358-105E7	108.11	34.62	0.00	2.12	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	175.16	78.64	2.29	3.21	0.46	1.60	0.92
temporal lobe, adult, pool1	10031-101E4	73.24	43.83	2.54	0.76	0.42	0.68	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	37.04	2.85	0.71	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	62.85	42.64	3.08	0.88	0.88	0.44	0.44
tenocyte, donor1	11763-123H8	28.98	30.37	0.35	0.70	0.35	1.40	0.35
tenocyte, donor2	11765-123I1	44.64	22.51	0.00	0.00	0.00	0.00	1.14
tenocyte, donor3	11768-123I4	53.01	25.21	1.85	0.00	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	242.19	195.79	5.27	4.25	1.02	2.21	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	95.57	97.88	0.92	4.47	0.92	0.31	0.15
teratocarcinoma cell line:PA-1	10807-111A6	119.02	116.23	1.39	2.48	0.93	0.31	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	178.74	93.31	2.29	3.94	1.02	1.02	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	228.04	107.78	2.65	4.16	1.13	1.51	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	311.16	68.49	4.04	1.20	0.87	1.53	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	135.82	145.59	4.89	4.56	1.63	0.65	0.33
testis, adult, pool1	10026-101D8	34.90	30.92	0.97	25.77	15.78	0.21	5.91
testis, adult, pool2	10096-102C6	35.18	27.07	2.26	21.65	15.79	0.90	9.47
thalamus - adult, donor10196	10168-103B6	85.01	51.89	3.31	2.21	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	133.93	95.33	3.75	2.19	0.63	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	98.54	84.68	9.24	0.00	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.33	23.55	0.99	1.15	0.66	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	239.91	30.49	6.33	5.18	1.15	1.15	0.00
throat, adult	10209-103G2	37.20	43.69	0.50	3.50	0.50	0.50	0.00
throat, fetal, donor1	10061-101H7	31.38	37.48	1.52	1.83	0.91	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	163.75	41.14	3.38	0.40	0.40	0.40	0.00
thymus, adult, pool1	10027-101D9	47.22	58.65	2.98	2.29	1.79	1.19	0.80
thymus, fetal, pool1	10043-101F7	173.83	48.94	11.33	1.97	1.87	4.99	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	134.56	77.38	1.33	2.39	0.66	0.93	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	103.93	78.09	1.26	1.96	1.40	0.42	0.84
thyroid, adult, pool1	10028-101E1	83.33	54.40	0.93	1.21	1.21	0.09	0.65
thyroid, fetal, donor1	10060-101H6	26.63	29.00	1.05	1.05	0.53	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	21.56	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	37.91	31.86	1.40	0.70	0.47	0.93	0.70
tongue, fetal, donor1	10059-101H5	46.11	55.96	0.39	2.36	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	39.57	43.18	0.90	0.60	0.40	0.00	0.30
trachea, adult, pool1	10029-101E2	53.58	36.81	0.74	1.06	0.90	0.16	0.33
trachea, fetal, donor1	10058-101H4	46.93	29.24	1.15	0.00	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	88.92	26.57	0.35	0.35	0.35	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	86.22	81.56	1.52	2.13	1.01	0.20	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	81.01	58.91	0.94	1.57	0.31	0.31	0.31
tridermal teratoma cell line:HGRT	10694-109G1	72.30	55.17	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	70.01	24.97	1.95	1.35	0.08	0.34	0.59
umbilical cord, fetal, donor1	10057-101H3	22.95	25.04	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	39.07	39.93	0.85	0.34	0.34	0.00	0.00
uterus, fetal, donor1	10055-101H1	51.70	43.00	2.56	0.51	0.00	1.54	0.00
vagina, adult	10204-103F6	587.39	61.39	2.58	0.00	0.00	1.94	1.94
vein, adult	10191-103E2	32.44	35.51	2.41	0.66	0.22	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.65	31.78	5.07	0.00	0.00	0.00	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000406752.1:-129 AY423723:-130 AF275803:-188 BC078151:-219 BC067823:-234 AF057356:-243 AL035305:-246 BC022352:-251 AF314752:-253 AK294042:-268 BC005865:-318 AK313278:-345 ENST00000473925.1:-355 BC005975:-355 ENST00000367679.7:-363 NM_014412.3:-363 ENST00000483307.1:-365" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.